+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Observations on carbapenem resistance by minimum inhibitory concentration in nosocomial isolates of Acinetobacter species: an experience at a tertiary care hospital in North India



Observations on carbapenem resistance by minimum inhibitory concentration in nosocomial isolates of Acinetobacter species: an experience at a tertiary care hospital in North India



Journal of Health, Population, and Nutrition 26(2): 183-188



Acinetobacter species are emerging as an important nosocomial pathogen. Multidrug-resistant Acinetobacter spp. has limited the option for effective treatment. Although carbapenems are effective for the treatment of such infections, resistance to this drug has recently been reported. This study was undertaken to assess resistance to carbapenem in clinical isolates of Acinetobacter spp. from hospitalized patients by both disc-diffusion and minimum inhibitory concentration (MIC) methods. All clinical samples from suspected cases of nosocomial infections were processed, and 265 isolates were identified as Acinetobacter species. These isolates were tested for antibiotic resistance by the disc-diffusion method with 14 antimicrobials, including meropenem and imipenem. Thereafter, all Acinetobacter species were subjected to MIC for meropenem. More than 80% resistance to second- and third-generation cephalosporins, aminoglycosides, and quinolones was recorded. Thirty percent of the strains were resistant to cefoperazone/sulbactam. Resistance to meropenem was observed in 6.4% of Acinetobacter spp. while 8.3% of the isolates showed intermediate resistance detected by MIC. All carbapenem-resistant/intermediate strains were also resistant to other (>10) antibiotics tested by the disc-diffusion method. The rising trend of resistance to carbapenem poses an alarming threat to the treatment for such infections. Regular monitoring, judicious prescription, and early detection of resistance to carbapenem are necessary to check further dissemination of drug resistance in Acinetobacter spp.

(PDF emailed within 0-6 h: $19.90)

Accession: 032607432

Download citation: RISBibTeXText

PMID: 18686551

DOI: 10.2307/23499490


Related references

Characterization and changing minimum inhibitory concentration (MIC) of Acinetobacter species from a tertiary care setup. Journal of Communicable Diseases 37(2): 99-107, 2006

Prevalence and phenotypic characterisation of carbapenem resistance in Enterobacteriaceae bloodstream isolates in a tertiary care hospital in India. International Journal of Antimicrobial Agents 37(3): 273-275, 2011

Deciphering polymyxin B minimum inhibitory concentration from colistin minimum inhibitory concentration and vice versa: An analysis on 156 carbapenem-resistant Enterobacteriaceae isolates. Indian Journal of Medical Microbiology 36(4): 587-589, 2019

Antibiotic resistance pattern of Enterococci isolates from nosocomial infections in a tertiary care hospital in Eastern India. Journal of Natural Science, Biology, and Medicine 6(2): 394-397, 2015

Carbapenem Resistance among Enterobacter Species in a Tertiary Care Hospital in Central India. ChemoTherapy Research and Practice 2014: 972646, 2014

Molecular Characterization of Carbapenem Resistant Isolates of Acinetobacter baumannii in An Intensive Care Unit of A Tertiary Care Centre at Central India. Journal of Clinical and Diagnostic Research 8(5): Dc38-Dc40, 2014

Analysis of carbapenem-resistant Acinetobacter from a tertiary care setting in North India. Indian Journal of Medical Microbiology 31(1): 60-63, 2013

Genetic linkage of blaNDM among nosocomial isolates of Acinetobacter baumannii from a tertiary referral hospital in northern India. International Journal of Antimicrobial Agents 41(5): 452-456, 2013

Characterization of carbapenem-resistant Acinetobacter baumannii clinical isolates in a tertiary care hospital in Saudi Arabia. New Microbiologica 37(1): 65-73, 2014

Contribution of efflux pumps in fluroquinolone resistance in multi-drug resistant nosocomial isolates of Pseudomanas aeruginosa from a tertiary referral hospital in north east India. Indian Journal of Medical Microbiology 33(1): 84-86, 2016

Molecular Characterization of Invasive Carbapenem-Resistant Acinetobacter baumannii from a Tertiary Care Hospital in South India. Infectious Diseases and Therapy 5(3): 379-387, 2016

Neonatal septicemia isolates and resistance patterns in a tertiary care hospital of North India. Journal of Infection in Developing Countries 4(1): 55-57, 2010

Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii clinical isolates from the respiratory department of a tertiary care hospital in Henan, China. Journal of Global Antimicrobial Resistance 3(4): 309-310, 2016

Prevalence of inducible clindamycin resistance among Staphylococcal isolates in a tertiary care hospital in North India. Indian Journal of Medical Microbiology 33(2): 327-328, 2015

Molecular characterization and resistance profile of nosocomial Acinetobacter baumannii intensive care unit of tertiary care hospital in Bangladesh. Bangladesh Medical Research Council Bulletin 41(2): 101-107, 2015